✦ LIBER ✦

Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab

✍ Scribed by Anjali V. Morales; Ranjana Advani; Steven M. Horwitz; Nadeem Riaz; Sunil Reddy; Richard T. Hoppe; Youn H. Kim

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab treatment in primary cutaneous

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Treatment of primary cutaneous B-cell ly

✍ Regina Fink-Puches; Ingrid H. Wolf; Iris Zalaudek; Helmut Kerl; Lorenzo Cerroni 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 181 KB

MicroRNAs as prognostic markers in indol

✍ Monsálvez, Veronica; Montes-Moreno, Santiago; Artiga, María J; Rodríguez, Maria 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 825 KB

Intralesional rituximab in the treatment

✍ Y. Peñate; B. Hernández-Machín; L.I. Pérez-Méndez; F. Santiago; B. Rosales; O. S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

Primary cutaneous B-cell lymphoma mimick

✍ M-C. Lami; P. Vabres; B. Dreyfus; T. Germain; G. Guillet 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Treatment of CD20+ B-cell cutaneous lymp

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB